SCHEMBL25715926

SCHEMBL25715926

CC(C)OC(=O)[C@H](C)NP(=O)(OC[C@H]1O[C@@H](n2cnc3c(=O)[nH]c(N)nc32)C[C@@H]1C)Oc1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.48
CYP2C9 P11712 2/20 0.48
POLB P06746 1/20 0.48
TAS1R3 Q7RTX0 1/20 0.45
TAS1R1 Q7RTX1 1/20 0.45
P2RY2 P41231 1/20 0.44
P2RY4 P51582 1/20 0.44
P2RY6 Q15077 1/20 0.44
HINT1 P49773 2/20 0.43
FUT5 Q11128 1/20 0.43
TGM2 P21980 1/20 0.42
TAAR1 Q96RJ0 1/20 0.42
NT5E P21589 1/20 0.41
KRAS P01116 3/20 0.39
GSK3A P49840 1/20 0.39
RPS6KA3 P51812 1/20 0.39
MAPK14 Q16539 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22348826 0.93 POLB (0.57) CYP3A4CYP2C9POLBTAS1R3TAS1R1
SCHEMBL23187769 0.93 POLB (0.57) CYP3A4CYP2C9POLBTAS1R3TAS1R1
SCHEMBL29944545 0.93 POLB (0.57) CYP3A4CYP2C9POLBTAS1R3TAS1R1
SCHEMBL21162576 0.93 POLB (0.57) CYP3A4CYP2C9POLBTAS1R3TAS1R1
SCHEMBL17198467 0.92 CYP3A4 (0.48) CYP3A4CYP2C9POLBTAS1R3TAS1R1
SCHEMBL17198258 0.92 CYP3A4 (0.48) CYP3A4CYP2C9POLBTAS1R3TAS1R1
SCHEMBL17198510 0.92 CYP3A4 (0.48) CYP3A4CYP2C9POLBTAS1R3TAS1R1
SCHEMBL17198632 0.92 CYP3A4 (0.48) CYP3A4CYP2C9POLBTAS1R3TAS1R1
SCHEMBL17198533 0.92 CYP3A4 (0.48) CYP3A4CYP2C9POLBTAS1R3TAS1R1
SCHEMBL17198257 0.92 CYP3A4 (0.48) CYP3A4CYP2C9POLBTAS1R3TAS1R1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3131914-B1 3'-SUBSTITUTED METHYL OR ALKYNYL NUCLEOSIDES FOR THE TREATMENT OF HCV IDENIX PHARMACEUTICALS LLC (US) 2023-05-10 EP disclosed